OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Miles Wang, an OpenAI researcher, is leaving the company to start a new startup focused on AI-driven drug discovery, with plans to raise $200 million at a $2 billion valuation. The startup aims to leverage AI to accelerate scientific and biological discovery, potentially using existing drugs or those that failed in trials. Wang’s previous work included using AI to enhance drug discovery efforts, and the company’s focus aligns with broader trends in applying AI to pharmaceutical research.
More from Techcrunch
Microsoft kills off unsuccessful AI features while merging its separate Copilot apps
Microsoft is simplifying Copilot by combining its consumer and business apps, and dropping AI-generated podcasts, Group Chats, Deep Research, and its Mico character.
techcrunch.com··Mads Kristian Nylund·AI ToolsAI InfrastructureAI Governance
Nvidia’s new $500B plan is risky but brilliant, especially for aging GPUs
Nvidia has a plan to make sure its GPUs won't lose value. It wants to convince a new crop of financiers to keep lending for AI buildouts.
techcrunch.com··Mads Kristian Nylund·AI DevelopmentAI InfrastructureAI Governance
Apple in talks to pay publishers to provide Siri with current news: report
The tech giant has considered a nine-figure budget for the payments, according to the WSJ.
techcrunch.com··Mads Kristian Nylund·AI ToolsAI EthicsAI Platforms